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Drs Böckler, Allenberg, and Schumacher
(left to right)w
doi:10.1016/j.jtcvs.2006.02.056bjective: To outline the complications after endovascular repair in patients with
cute symptomatic and chronic expanding Stanford type B aortic dissections.
ethods: Between 1997 and 2004, of 125 patients with acute and chronic aortic type
dissections, 88 were treated conservatively. Thirty-seven patients (29 male, mean
ge 58 years, range 30-82 years) underwent endovascular repair (30%) using 44
tent grafts of 3 different designs: Excluder (W. L. Gore & Associates, Inc,
lagstaff, Ariz), Talent (Medtronic Vascular, Santa Rosa, Calif), and Endofit (En-
omed, Inc, Phoenix, Ariz). Indications for treatment were acute symptomatic type
dissection in 15 patients, chronic expanding aortic dissection greater than 55 mm
n 14, rupture in 3, and simultaneous type A repair in 5 patients. Twenty-two
perations were performed on an emergency basis. Patient characteristics, proce-
ural variables, outcome, and complications were prospectively recorded. All pa-
ients underwent follow-up by computed tomography before discharge, at 6 and 12
onths, and annually thereafter (mean follow-up: 24 months).
esults: Correct deployment was achieved in 97% of cases. There were no instances
f primary conversion, paraplegia, or stroke. Complete false lumen thrombosis was
bserved in 11 patients (44%). Perioperative complication rate was 22%. Thirty-day
ortality rate in acute and chronic dissections was 19% and 0%, respectively.
reedom from aortic reintervention was 81%, 73%, and 68%, freedom from late
upture was 97%, 90%, and 80%, and overall success rate was 76%, 65%, and 57%
t 1, 2, and 5 years, respectively. Results for patients with chronic dissections are
ignificantly (P  .038) better than results in those with acute dissections.
onclusions: Despite the minimally invasive approach, the complication and mor-
ality rates for endovascular therapy of aortic dissections are still high. Frank reporting
f these sequelae is if great importance to clarify the recent limitations of the
ethod.
ortic dissection is most often a catastrophic event which, if untreated, can
be potentially life threatening. In a population-based longitudinal study,
Meszaros and associates1 report mortality rates of acute untreated ao
issection of 22.7%, 50%, and 68% within 6 hours, 24 hours, and the first week,
espectively. The International Registry of Acute Aortic Dissection (IRAD) study,
ith an overall mortality of 27.4%, confirmed that aortic dissection is a lethal
isease.2 Open surgical repair also is associated with high morbidity and mort3
The advent of endovascular prostheses to treat descending thoracic aortic lesions
ffers an alternative approach in patients with dissections and severe comorbidities
ho are poor candidates for open surgery.4,5
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Surgery for Acquired Cardiovascular Disease Böckler et al
3However, endoluminal treatment is not without compli-
ations.6-8 Therefore, it is vital to report considerable c-
lication rates and the midterm outcome after endografting.
ence, this report describes a continuing singe-center ex-
erience with endoluminal stent-graft repair in acute com-
licated and chronic expanding aortic type B dissections,
ocusing on limitations and complications of endovascular
anagement.
atients and Methods
etween March 1997 and December 2004 (an 8-year period), 125
onsecutive patients presented with acute and chronic Stanford
ype B dissections in our department. In all cases, diagnosis was
onfirmed with computed tomography (CT) or magnetic resonance
maging. Thereby, retrograde involvement of the ascending aorta
nd arch were excluded. Eighty-eight (70%) were treated conser-
atively and were followed-up routinely by CT scan on an annual
asis. Thirty-seven patients with aortic dissection underwent trans-
uminal endovascular stent-graft placement.
atients
atient evaluation, selection, and endovascular procedures were
erformed by vascular surgeons. All patients with suitable aortic
orphologic characteristics were offered a stent graft as our pre-
erred alternative to open repair. Clinical characteristics, imaging,
nd procedural data were documented prospectively. Fifty-nine
ercent (n  22) of all operations were emergency interventions.
For this study, the records of 29 men and 8 women (mean age
7 years, range 30-82 years) were reviewed. Patient characteris-
ics, indications, stent-graft data, and results of treatment are
ummarized in Table E1. Fifteen patients had visceral, renal, o
schemia with true lumen collapse (TLC), and 3 had rupture of the
alse lumen (1 presenting with aortobronchial fistula [ABF] 2 years
fter initial uncomplicated dissection). Fourteen patients had
hronic expansive aortic dissection (CEAD) greater than 55 mm of
aximum diameter. All patients treated on an emergency basis had
ome degree of chest pain as the first presenting symptom. Five
atients were treated by endografting after type A dissection
epair: 2 immediate repairs in cooperation with cardiac surgeons (2
ntegrade deployments necessitated by bleeding at the distal anas-
omosis of the arch repair) and 3 staged procedures necessitated by
LC with malperfusion syndrome (1 visceral, 1 renal ischemia)
nd due to chronic aneurysmal expansion and consecutive infra-
Abbreviations and Acronyms
ABF  aortobronchial fistula
CEAD chronic expansive aortic dissection
CT  computed tomography
IRAD  International Registry of Acute Aortic
Dissection
TLC  true lumen collapseenal aortic rupture via transfemoral access. p
62 The Journal of Thoracic and Cardiovascular Surgery ● Augure-procedural Imaging
ll patients underwent spiral contrast-enhanced CT angiography
ith 3-mm slices and 3-dimensional reconstruction (Leonardo Work-
tation; Siemens AG, Erlangen, Germany; and Vitrea 2 worksta-
ion; Vital Images, Inc, Plymouth, Minn). Entry site, intended
anding zone and diameter, distribution of abdominal vessels,
ength of dissection, and involvement of iliac arteries to evaluate
he suitability for vascular access were determined. Measuring
f the aortic arch diameter and the proximal anchoring zone was
erformed in the so-called “centerline” at the work station. Ow-
ng to the fragility of the aortic wall, oversizing was performed
ery gently (10%) and only self-expanding endografts were
mplanted.
evice Details and Stent-Graft Placement
ix patients received more than 1 stent graft system simulta-
eously. Five patients received 2 devices and 1 patient received 3
evices. In total, 44 stent graft systems were implanted: 34 Ex-
luder thoracic endoprostheses (TAG; W. L. Gore & Associates,
nc, Flagstaff, Ariz), 9 Talent endoluminal stent grafts (Medtronic
ascular, Santa Rosa, Calif), and 1 Endofit thoracic endoprosthesis
Endomed, Inc, Phoenix, Ariz) with lengths from 100 to 220 mm
nd diameters between 28 and 40 mm. The median stent graft–
overed aortic segment was 169 mm (range 100-220 mm). Two
urgeons equally qualified in endovascular experience performed
ll endovascular procedures with the patients under general anes-
hesia in an operating theater equipped with fluoroscopic and
ngiographic capabilities (series 9800; OEC Medical Systems, Inc,
alt Lake City, Utah) and a carbon-fiber operating table. Each
atient received single-shot antibiotic therapy and 3000 units of
eparin intravenously. With the exception of 1 patient (No. 30:
ntegrade approach during aortic arch repair), vascular access was
btained in 29 patients via the common femoral artery and in 7
atients by implanting a temporary 10-mm Dacron conduit to the
ommon iliac artery because of small vessel size. The nondissected
liac/femoral artery, if iliac vessels were affected, was preferred for
ccess. A 0.035-inch guide wire (Terumo, Frankfurt, Germany)
as advanced and exchanged for a 7F calibrated angiography
atheter. Digital subtraction angiography was performed with ap-
ea followed by manual injection of 20 mL of nonionic contrast
edium (Iopamidol [Solutrast 300], Byk Gulden, Konstanz, Ger-
any). The aortic arch was rotated to about 45° in the left anterior
blique projection to adjust the parallax error for exact visualiza-
ion of the proximal landing zones (minimum 15 mm). A sheath
up to 26F) was inserted over the guide wire and exchanged with
0.035-inch, 260-cm Amplatz Super Stiff guide wire (Boston
cientific, Ratlingen, Germany) and passed to the aortic arch.
emporary adenosine-induced cardiac arrest with an average dose
f 60 mg was used for precise endograft placement in 26 patients.
dditionally, all patients were provided with external pacemakers.
allooning was not performed. Transesophageal echocardiogra-
hy was not used routinely during deployment, and there was no
tandby heart-lung machine. Completion angiography was per-
ormed to assess accurate placement and exclusion of the entry site
f the dissection. Stent grafts were only deployed at the entry sites
o depressurize the false lumen and to induce thrombosis. Stent
rafting of longer aortic segments was avoided because of fear of
araplegia. To achieve a sufficient proximal anchoring zone in
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Böckler et al Surgery for Acquired Cardiovascular Diseaseatients with CEAD and without any healthy landing zone, we
erformed one transposition of the left subclavian artery alone and
olytetrafluoroethylene crossover bypass of both left common
arotid and subclavian arteries in 2 patients before elective
ndografting.
ollow-up
ollow-up status between 1997 and 2004 is 100% complete and
as performed in our department The follow-up protocol included
ostoperative contrast-enhanced CT scanning and plain chest ra-
iography before hospital discharge, 6 months and 12 months after
ndografting, and annually thereafter. The mean follow-up is 24
onths (range 0-56 months). Cause of death was obtained by
edical reports or by contacting the primary care physician.
efinitions
y definition, acute type B dissection is present when diagnosis is
ade within 2 weeks after the initial onset of symptoms. Primary
uccess was defined as insertion and accurate placement of the
tent graft in the intended landing zone, successful immediate
ntry occlusion, and lack of immediate perioperative complica-
ions without any additional interventions. End points and criteria
or late outcome were false lumen thrombosis of the thoracic aorta,
ack of thoracic aorta expansion, and freedom from rupture. En-
oleak is defined as radiologic evidence of blood flow outside the
tent graft according to published guidelines, except persistent
etrograde false lumen perfusion.9 Reintervention is defined as an
eed for surgical or endovascular intervention on the treated aortic
egment during follow-up. Treatment failure was defined as prox-
mal type I endoleak, perioperative death, aortic reintervention,
issection-related death, and all sudden unexplained late deaths
uring follow-up.
tatistical Analysis
omparison of acute and chronic dissections was done by the
ilcoxon signed-rank test. Kaplan-Meier life-table survival anal-
sis was performed with XLSTAT V7.5.2 software (Addinsoft,
ew York, NY).
esults
arly Outcome
Procedural success. The overall primary technical suc-
ess rate was 97%: Stent grafts were deployed successfully
n all but 1 patient in whom device tracking was difficult.
ndovascular repair was successfully performed in a second
ntervention 4 days later. The left subclavian artery was
overed intentionally in 13 patients for tight proximal fix-
tion and secure device attachment. One patient received an
mmediate subclavian-carotid bypass after inadvertent par-
ial covering of the left carotid artery resulting from inac-
urate placement. No primary conversion or additional si-
ultaneous intervention was needed. The perioperative
omplication rate was 22% (cardiac 2, pulmonary 3, retro-
rade dissection 1, acute renal failure 1, subclavian steal
yndrome 1). Paraplegia or stroke was not observed. One
atient had subclavian steal syndrome and underwent by- e
The Journal of Thoracicass grafting 2 days later. The perioperative additional
eintervention rate was 13.5% (acute 18%, chronic 7%).
wo patients required early aortic reintervention because of
etrograde dissection and infrarenal rupture on day 5 (5.4%).
verall perioperative mortality (30 day) was 19%, all in
cute cases. Multiorgan failure (n  4) as the leading cause
f death was observed predominantly in patients with con-
inuing visceral ischemia. Five of 6 patients with TLC and
esenteric ischemia showed a drop of lactate and liver
nzymes 12 hours after endovascular entry occlusion, and a
eturn to normal on average 4.5 days after the intervention.
50-year-old man with TLC and a 2-day history of ab-
ominal pain, primarily treated successfully with immediate
e-expansion of the true lumen on completion angiography,
eveloped colon ischemia and multiorgan failure and died 2
ays after subtotal colectomy. Two patients with compli-
ated type A dissection died perioperatively; 1 died of
espiratory failure and 1 of a bleeding disorder (Tabl
hirty-day mortality was 10% for type B dissections and
7% for type A dissections.
ate Outcome
Survival. The overall survival at 1, 2, and 5 years after
ndografting was 81%, 64%, and 64%, respectively (Figur
here is significant difference (P  .038) in survivals be-
ween patients with acute and chronic type B dissections
Table 2, Figure 2). Overall mortality totals 27%. Caus
arly and late deaths are listed in Table 1.
Endoleaks and material fatigue. On postoperative CT
canning, one type II endoleak and one late proximal type I
ndoleak were diagnosed. This patient, initially treated for
EAD, primarily refused secondary intervention and finally
as treated by a proximal extension graft. The proximal
ndoleak persisted because of a diameter mismatch of the
ndograft and the aortic arch. The patient died of infrarenal
alse lumen rupture while she was scheduled for secondary
onversion (No. 17). Plain chest radiographs showed no
ire form fractures in any patients.
Reintervention. Freedom from aortic reintervention av-
ABLE 1. Causes of early and late deaths in 37 patients
Early
deaths
Late
deaths
ultiorgan failure, mesenteric ischemia 3
ultiorgan failure, hepatic failure 1
isseminated bleeding disorder 1
nfection, sepsis 1
espiratory failure, aspergillosis 1
rain edema, central respiratory failure 1
ortobronchial fistula, hemoptysis 1
ardiac failure 2
nfrarenal aortic rupture 1raged 81%, 73%, and 68% at 1, 2, and 5 years: in acute
and Cardiovascular Surgery ● Volume 132, Number 2 363
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Surgery for Acquired Cardiovascular Disease Böckler et al
3ases, 82%, 73%, and 73%; in chronic cases, 80%, 74%,
nd 60% (P  .412) (Figure 3). During follow-up, 
onversion (stent-graft explantation) was performed. One
econdary proximal type I endoleak was diagnosed. In this
atient (No. 17), initially treated for CEAD, a second prox-
mal extension graft was inserted. The proximal endoleak
ersisted because of a disproportion of the different diam-
ters of the endograft and aortic arch. She died of infrarenal
alse lumen rupture while she was scheduled for secondary
onversion. A 78-year old man (No. 23) with ABF was
reated by transfemoral coiling embolization of the false
umen to avoid conversion in a high-risk patient. He died 2
eeks later of another massive hemorrhage. One female
atient with Marfan syndrome had chronic visceral aortic
xpansion and was treated with a hybrid procedure (case
iscussed later). Two more patients received aorto-biiliac
ypass grafting 3 years after stent grafting.
Aortic rupture. Patient 23 had a rupture from the false
umen with ABF at 18 months. Repetitive hemoptysis after
ndograft placement was unsuccessfully treated earlier with
oil embolization of the false lumen (Figure E1). Patien
s reported, had infrarenal rupture just before elective con-
ersion. Actual freedom from rupture was 97%, 90%, and
0% at 1, 2 and 3 years, respectively.
False lumen thrombosis. Among 26 survivors, partial
alse lumen thrombosis of the stented aortic segment was
Figure 1. Overall survival rate. CI, Confidence interval.
ABLE 2. Overall survivals of patients with acute, chronic,
nd overall type B dissection
Survival (%)
1 year 2 years 5 years
cute 62 62 62
hronic 100 90 72
verall 81 64 64
64 The Journal of Thoracic and Cardiovascular Surgery ● Augu,
nduced in 7 patients and retrograde perfusion persisted by
istal re-entries. Thrombosis of the false lumen of the entire
escending thoracic aorta was observed only in 11 patients
44%). A still patent false lumen was observed in 3 patients.
Chronic abdominal aortic expansion. Overall expan-
ion rate was 32% (12/37) and 48% among survivors. Only
2 patients (acute, chronic) showed no enlarged aortic di-
meter during follow-up. Expansion by more than 30 mm
ut less than 50 mm was seen in 7 patients with continuing
urveillance by CT scan. Five patients (3 chronic, 2 acute)
eveloped aortic expansion of more than 50 mm over a
-year period, and except for 1, all underwent open abdom-
nal aortic bifurcated bypass grafting. One female patient
No. 19) with Marfan syndrome had progressive dilatation
f the abdominal aorta after valve replacement and thoracic
igure 2. Rates of freedom from procedure-related death in pa-
ients with acute and chronic type B dissection.Figure 3. Rates of freedom from secondary interventions.
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Böckler et al Surgery for Acquired Cardiovascular Diseasendografting of the distal arch. In a staged hybrid procedure,
he was treated by extra-anatomic mesenteric and renal
evascularization and endografting of the thoracoabdominal
orta (Figure 4).
Total treatment failure. Actual freedom from all post-
perative events (treatment failure including death) was
6%, 65%, and 57% at 1, 2, and 5 years, respectively.
atients with chronic dissections do significantly (P .034)
etter than those with acute dissections (64%, 50%, and
5% vs 93%, 87%, and 73%) (Figure 5).
iscussion
ortic treatment paradigms have evolved with the develop-
ent of endovascular stent-graft repair of thoracic aortic
neurysms, which started at Stanford in 1992.10 The same
uthors published the only available study describing mid-
erm results (4.5 years) of endovascular stent-graft repair of
 thoracic aneurysm.11 Although there are no long-term d
o support definitive evidence, endovascular treatment is
lso proposed as an alternative therapy in patients with type
dissections. Whether stent grafting provides lasting pro-
igure 4. A, Three-dimensional reconstruction of postoperative
T scanning shows patent open retrograde bypass reconstruction
f the celiac trunk, superior mesenteric artery, and left renal
rtery, a separate retrograde revascularization of the right renal
rtery (8-mm Dacron graft), and complete endovascular repair of
he thoracoabdominal aneurysmal expanded aorta with 4 TAG
evices (28-100 and 31-150 mm in reversed thrombone technique).
, Retrograde false lumen reperfusion is still documented, orig-
nating from the left common iliac artery.ection from aortic rupture (especially false lumen rupture), a
The Journal of Thoracicrom chronic aortic expansion, or from end organ ischemia
till has to be determined. Therefore, we analyzed our
idterm results for endovascular therapy on patients with
ype B aortic dissections.
The specific findings of this study highlight the prob-
ems and open questions of endovascular treatment in
ortic dissections: The 30-day mortality rate of acute type
dissections after endograft implantation is still high
19%); in type A dissections it is as high as 57%. These
isparate mortality rates likely pertain to patient selection
ias and the acuity or pretreatment physiologic status of
he patients. The high percentage of emergency interven-
ions in this study (59%) and no diagnosis or delayed
iagnosis of visceral ischemia in the prehospital time
eriod may be a cause for patients dying of multiorgan
ailure despite technically successful entry closure. Many
uthors have published results on transluminal placement
f endovascular stent grafts for the treatment of descend-
ng thoracic aortic dissections (Table 3).12-14 Dake and
ssociates4 reported a series of 19 acute symptoma
issections with 16% early mortality. This is in line with
he 19% mortality in our own series. Early mortality in a
hird study from Palma and coworkers15 published an
arly mortality of 6% in 58 patients, and of those, 35 had
cute dissection but were asymptomatic. A comparative
tudy of both therapy modalities, “endovascular versus
onservative,” for uncomplicated courses of asymptom-
tic patients is currently running. The excellent results
chieved in 82 patients by Rehders and Nienhaber16 are
ifficult to interpret because of a lack of differentiation
etween acute and chronic dissections, ruptures, and
schemia. Frequently, no difference between the results
f asymptomatic and symptomatic patients has been
ade. Numerous retrospective studies with univariate
igure 5. Rates of freedom from any adverse event (treatment
ailure).nd multivariate data analysis have been carried out to
and Cardiovascular Surgery ● Volume 132, Number 2 365
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Surgery for Acquired Cardiovascular Disease Böckler et al
3efine those initial factors of the acute phase that deter-
ine the clinical course and the long-term prognosis5,17
esenteric ischemia has a major impact on outcome.
wo of our patients died of multiorgan failure because of
isceral ischemia and unresolved malperfusion persisting
ostoperatively. One 48-year-old male patient (No. 27),
ho was stent grafted with clinically asymptomatic ab-
omen but occlusion of the celiac trunk and superior
esenteric artery, developed severe colon ischemia and
ied despite early entry closure within 48 hours. Mal-
erfusion remains a major challenge. If mesenteric isch-
mia is suspected, an aggressive posture toward laparot-
my or laparoscopy is appropriate, even if endovascular
evascularization has been achieved. Following labora-
ory values for potential markers of mesenteric infarction
an be crucial. Four of our patients died because of
elayed recognition.
Long-term data suggest that up to 40% of asymptom-
tic patients will die of aorta-related causes or require a
irect aortic reintervention over a 7-year period.18 Thirty
ercent to 40% of all symptomatic patients have complica-
ions over the further clinical course.1 Consequently, achieve-
ent of complete false lumen thrombosis and prevention of
ortic growth and expansion is the main goal in the treat-
ent of dissections. We observed complete or false lumen
hrombosis only in 44% of patients and severe visceral
ortic expansion over 50 mm in 5 patients. In the series
eported by Kato and associates,17 only 38.5% of chroni
issections showed complete obliteration during 27 months
f follow-up.
Patients after type A repair and residual type B dis-
ections are also potential candidates for “hybrid” distal
tent grafting. The 30-day mortality of this approach in
ur series of 57% is closely related to complications after
ype A repair, to a sick and small cohort of 5 patients, and
eeds skeptical judgment. The strategy of immediate
ybrid repair of the ascending and descending aorta in-
luding technical considerations of antegrade versus ret-
ograde stent-graft deployments needs definitive future
ABLE 3. Selected literature review of endovascular thera
irst author Patients (n) Type of dissection
ake (1999)4 19  A 4 B 15  
ienhaber (1999)5 12  A 0 B 12  
ehders (1999)16 94 — 
nce (2000)26 120 — 
onn (2002)27 41 — 
rendt (2003)19 14 B 14 
wn series (2004) 37 A 7 (with descending tear,
symptomatic) B 30valuation. a
66 The Journal of Thoracic and Cardiovascular Surgery ● AuguSpinal cord ischemia after stent-graft repair of dissec-
ions varies between 3% and 10% in the literature,19 0%
n this study.19 Potential factors for the lower inciden
f spinal cord ischemia during endovascular repair are
dequate collateral blood supply, no aortic crossclamp-
ng, short extension of stent graft– covered aorta, and
eployment positioning far from the suggested origin of
he artery of Adamkiewicz.
Sufficient proximal anchoring of 2 cm is necessary to
void a proximal type I endoleak. To achieve this, cov-
rage of the left subclavian or combined conventional
ransposition of the aortic arch branches may be neces-
ary (Figure E2). We covered the left subclavian arte
3 patients. One patient had clinically moderate dizziness
nd was observed without secondary intervention. Two
atients had a proximal type I endoleak. Causes were
ncorrect endograft sizing and inflexible devices for the
istal arch, which did not properly seal the proximal
nchoring zone. Proximal tight fixation in the distal arch
s mandatory and mostly makes covering the left subcla-
ian artery necessary.
The importance of the chronic expansion and the
actors of influence have been the subject matter of
umerous studies.17 An initial diameter of more than
m and a persistent entry into the false lumen have been
dentified as determinants for CEAD. Surgical interven-
ion rate and associated mortality is reported to be high
30%-40%).20 Overall expansion rate was 32% (12/3
nd 48% among survivors in this study underlines this
ignificant sequelae.
Asymptomatic patients with an open false lumen, an
nitially large aortic diameter greater than 40 mm, and
ngoing “open entry” face unfavorable prognostic fac-
ors.21 The 1-year and 5-year survivals of asymptoma
atients under conservative medication amount to 94%
nd 86%, respectively. A comparison of these patients,
owever, to others who have undergone surgical therapy
ith a significantly higher risk is not permissible.
In a multicenter study comprising 465 patients, Hagan
n patients with Stanford type A/B dissections
Technical
success (%)
Thirty-day
mortality rate
Major
complications
Mean
follow-up (mo)
100  3/19 4/19 4-28
100  0/12 — 12
100 0/94 5/94 12
98 2/120 — 12
87.8 — — 1-19
100 0/14 9/14 22
92 4/73/30 13/37 22py ind associates2 report a 3 times higher postoperative
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Böckler et al Surgery for Acquired Cardiovascular Diseaseortality rate (31.4%) as compared with the conservative
atient group (10.7%). Lansmann and colleagues,22 how-
ver, report a mortality of 0% with a fairly high associ-
ted complication rate of 47% in 34 patients with symp-
omatic type B dissection who had undergone surgery in
he acute phase. In 1999, Nienhaber and colleagu5
ublished a small study that was the first prospective
tudy to compare transluminal and open surgery, consti-
uting that stent-graft repair is a viable therapeutic option.
imitations
urther unanswered questions are the spontaneous course
f an asymptomatic radiologic “TLC” and its potential
nfluencing factors, which determine the fate of the true
umen. Experimental studies carried out by Chung and
ssociates23,24 could prove the effectiveness of overste-
ng the intimal rupture site (“entry”) for treatment of
LC. However, as long-term results are still lacking, it
emains to be seen whether this circumstance can be
lassified as a criterion of success or aim of therapy.
fter 2 years, false lumen thrombosis rate was only 44%.
ersisting perfusion of the false channel correlates with
ate complications CEAD and death due to rupture.23,24
he meaning of patent false lumen in the further clinical
ourse remains an open question. The term “true lumen
ollapse” (TLC) is difficult to interpret, as dissections are
ynamic events with membrane movements, which can
learly be demonstrated by cine magnetic resonance im-
ging. The development of a specific endograft design for
issection therapy will become necessary. There is no
deal stent graft for dissections yet. The characteristics
eeded are gentle and flexible design, with no radial force
nd no bare springs. An important issue is the rigidity of
he systems, which can cause penetration of the thin
embrane. Of all the commercially available thoracic
evices (Talent, Excluder, Endofit, and Zenith [Cook
ncorporated, Bloomington, Ind]), we prefer the Excluder
ndoprosthesis, because of its access size and good flex-
bility. Finally, proof of the concept that endografts pre-
ent long-term complications requires a prospective ran-
omized trial. Our own therapy concept provides
ndovascular treatment in the symptomatic acute stage
any kind of ischemia, symptomatic TLC) or during the
hronic course with aneurysmal expansion of more than
5 mm.22 Therefore, only 23% of 110 patients w
tanford type B dissection were selected for endovascu-
ar surgery.
onclusion
n summary, the concept of endoluminal entry occlusion
n acute or symptomatic type B dissections is promising
nd represents at least an alternative method of choice in
ymptomatic type B dissections. However, long-term fol-
1
The Journal of Thoracicow-up data are required and caution is needed using
ndovascular therapy, especially in asymptomatic pa-
ients. Of paramount importance is the reporting of com-
lications. According to our results, we continue to be
estricted with thoracic endografting in dissections. We
o not treat asymptomatic patients with uncomplicated
ourses and CEAD until the aortic diameter reaches more
han 55 mm.25 The concept of endovascular treatment 
ype B dissections should be subjected to randomized
valuation to settle all the answers.
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Böckler et al Surgery for Acquired Cardiovascular DiseaseFigure E1. Postembolization chest radiography in a patient who
had hemoptysis due to ABF 17 months after successful stent-graft
placement for aortic dissection. Coils were placed into the false
lumen above and below the detected and localized fistula tract.
Figure E2. Postoperative 3-dimensional reconstruction (Vitrea,
Vital Images) after transposition and crossover bypass grafting of
supra-aortic vessels and staged distal arch endografting to cre-
ate a suitable neck for proximal stentgraft fixation. A, Anterior
view. B, Posterior view (patent No. 34).The Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 2 368.e1
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3ABLE E1. Patient characteristics of 37 patients treated with endovascular stent graft placement for acute complicated
r chronic expanding aortic type B dissection (numbered consecutively to procedure date out of total 112 patients with
horacic endografting)
o./
onsecutive
atient
Age (y)/
sex
Acute (emergency) or
chronic
(elective)/indication
Endograft
model/size/No.
of grafts
AICA:/covered left
subclavian/simultaneous
conventional procedures Complications Outcome
1/16 36/M Acute/visceral ischemia/
previous ascending 
aortic valve
replacement, Marfan
syndrome
TAG/31-130/1 /yes/no Subclavian steal
syndrome 
bypass
Alive at 56 mo
2/18 38/M Acute/TLC, renal
ischemia, previous A
dissection
TAG/34-100/1 /yes/iliac-renal vein
bypass
Visceral ischemia,
MOF
Died at 1 mo of
MOF
3/22 71/M Acute/TLC, AAA 56 mm TAG/28-100/1 /no/no Acute coronary
syndrome, PTCA
and stenting on
day 3
Alive at 49 mo
4/23 35/M Chronic/TLC, chronic
renal and visceral
ischemia (weight loss
18 kg/3 mo)
TAG/26-100/1 /no/no Alive at 48 mo
5/28 61/M Chronic/prevention of
rupture—CEAD (60
mm), previous
ascending  arch
replacement
TAG/34-125/1 /no/aorto-biiliac
bypass
Alive at 47 mo
6/32 62/M Chronic/CEAD—
prevention of rupture/
previous ascending 
arch replacement
TAG/40-200/1 /yes/no Alive at 43 mo
7/33 58/M Chronic/CEAD,
prevention of rupture
TAG/34-200/1 /no/no Alive at 43 mo
8/35 40/M Acute/iIschemia left
kidney, left leg
TAG/28-150/1 Uncleared
retrograde A,
dissection
Died at 1mo of
MOF
9/39 79/F Acute/TLC and visceral
ischemia
FL—contained rupture
TAG/34-200/1 /yes/no Respiratory
insufficiency,
reintubation
Died at 1.5 mo of
cardiopulmonary
failure
10/40 44/F Acute/TLC, ischemia left
kidney, right leg
TAG/34-200/1 /yes/no Alive at 41 mo
11/42 78/M Acute/rCEAD TAG/28-150,
34-150, 40-
150 rev.
trombone/3
/no/no Endoleak type II,
pleural effusion
Alive at 37 mo
12/43 58/M Acute/TLC, visceral
ischemia
TAG/34-200,
34-100
thrombone/2
/no/no Alive at 32 mo
13/46 41/M Acute/Ehlers-Danlos TAG/37-200/1 /no/no Alive at 39 mo
14/47 62/M Acute/visceral ischemia TAG/34-200/1 /no/tube graft Alive at 39 mo
15/49 62/F Chronic/CEAD (65 mm),
prevention of rupture
TAG/34-200,
34-150
thrombone/2
/no/no Proximal endoleak
type I,
progressive FL,
expansion,
second proximal
endograft
Died at 21 mo of
infrarenal
rupture and
persisting
endoleak, while
waiting for
conversion
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o./
onsecutive
atient
Age (y)/
sex
Acute (emergency) or
chronic
(elective)/indication
Endograft
model/size/No.
of grafts
AICA:/covered left
subclavian/simultaneous
conventional procedures Complications Outcome
16/51 68/M Chronic/CEAD (mm) TAG/37-150/1 /no/no Alive at 39 mo
17/52 32/F Acute/Marfan TAG/31-150/1 /no /no Alive at 36 mo.
Distal aortic
expansion,
treated with
hybrid
procedure
18/60 80/M Acute TAG/37-150/1 /yes/no Aspergillosis,
long-term
ventilation
Died at 0.6 mo of
respiratory
failure
19/65 46/M Acute/visceral ischemia
and right leg ischemia
TAG/34-150/1 /yes/no Pneumonia,
delirium
Alive at 26 mo
20/73 62/M Chronic/CEAD—
prevention of rupture
(80 mm)
Endofit/38-220-
24/1
/yes/subclavian–
carotid bypass
Inadvertent partial
covering of the
left carotid
ostium
Alive at 20 mo
21/74 78/M Chronic/CEAD (55 mm)
and ABF
Talent/40-115,
42-115-40/2
/yes/no Persisting ABF,
secondary
endografting,
selective coiling
of the FL
Died at 18 mo of
massive
hemoptysis
22/79 67/M Acute/Marfan Talent/36-130/2 /no/renal stenting Alive at 18 mo
23/80 63/M Acute/penetrating aortic
ulcer
Talent/36-130
thrombone/2
/yes/no Alive at 17 mo
24/83 82/F Acute/TLC, renal and
leg ischemia
Talent/36-130/1 /yes/no Persisting visceral
ischemia
Died on day 1 of
MOF
25/85 48/M Acute/visceral ischemia Talent/34-130/1 /no/no Colon ischemia Died on day 3 of
MOF
26/91 60/M Chronic/CEAD (55 mm)/
renal cell carcinoma
TAG 34-150/1 /no/no Alive at 9 mo
27/93 60/M Chronic/CEAD (50 mm) TAG/34-200/1 /no/no Alive at 9 mo
28/96 61/M Chronic/CEAD (55 mm) TAG/34-150/1 /no/no Alive at 8 mo
29/97 65/M Acute/CEAD, contained
rupture FL,
hemothorax
TAG/34-200/1 /yes/no Acute renal
failure,
hemodialysis,
comatose
tracheal
respiration
Alive at 8 mo
30/100 48/F Chronic/CEAD—
prevention of rupture
(60 mm)
Talent/26-130/1 /no/no Alive at 6 mo
31/102 50/M Chronic/CEAD (mm), FL
rupture before,
conventional repair;
primary suturing
TAG/40-200/1 /yes/no Alive at 5 mo
32/105 50/M Chronic/CEAD (48 mm)
and large left
subclavian artery
TAG/37-150/1 /yes/yes Thoracotomy,
major bleeding
Alive at 3 moaneurysm
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3ABLE E1. Continued
o./
onsecutive
atient
Age (y)/
sex
Acute (emergency) or
chronic
(elective)/indication
Endograft
model/size/No.
of grafts
AICA:/covered left
subclavian/simultaneous
conventional procedures Complications Outcome
33/108 78/F Chronic/CEAD (62 mm) TAG/34-200/1 /yes/no Postoperative
asystole,
successful
reanimation,
hypovolemia
Alive at 2 mo
34/112 61/M Acute/persistent chest
pain, diameter at
entry site: 52 mm
TAG/34-200/1 /yes/no Alive at 0.5 mo
35/105 50/M Chronic/CEAD (48 mm)
and large left
subclavian artery
aneurysm
TAG/37-150/1 /yes/yes Thoracotomy
major bleeding
Alive at 3 month
36/108 78/F Chronic/CEAD (62 mm) TAG/34-200/1 /yes/no Postoperative
asystole,
successful
reanimation,
hypovolemia
Alive at 2 mo
37/112 61/M Acute/resistant chest
pain, diameter at
entry site: 52 mm
TAG/34-200/1 /yes/no Alive at 0.5 moEAD, Chronic expanding aortic dissection; rCEAD, ruptured; TLC, true lumen collapse; MOF, multiorgan failure; FL, false lumen; ABF, aortobronchial fistula.
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